InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Rodino-Klapac Louise, Directeur Scientifique. Officer active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 23 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €267k. History available since 16 November 2021. The latest transaction was filed on 11 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rodino-Klapac Louise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
948 shares@ US$17.030.5% of flowCommon StockSEC:0001193125-26-106703:0
504 shares@ US$16.950.3% of flowCommon StockSEC:0001193125-26-102703:0
8,125 sharesCommon StockSEC:0001193125-26-089425:0
4,582 shares@ US$18.422.7% of flowCommon StockSEC:0001193125-25-288556:0
93,875 shares0Common StockSEC:0001193125-25-197425:0
5,500 sharesCommon StockSEC:0000950170-25-037523:0
17,500 sharesCommon StockSEC:0000950170-25-036694:0
1,704 shares@ US$101.345.8% of flowCommon StockSEC:0000950170-25-035002:0
715 shares@ US$103.772.5% of flowCommon StockSEC:0000950170-25-032759:0
4,558 shares@ US$102.8915.7% of flowCommon StockSEC:0000950170-24-129454:0
6,250 sharesCommon StockSEC:0000950170-24-077521:0
512 shares@ US$120.492.0% of flowCommon StockSEC:0000950170-24-029532:0
1,728 shares@ US$125.327.0% of flowCommon StockSEC:0000950170-24-027496:0
778 shares@ US$126.193.2% of flowCommon StockSEC:0000950170-24-026607:0
4,508 shares@ US$82.9812.1% of flowCommon StockSEC:0001209191-23-056168:0
912 shares@ US$153.194.7% of flowCommon StockSEC:0001209191-23-018021:0
1,134 shares@ US$157.215.9% of flowCommon StockSEC:0001209191-23-017407:0
522 shares@ US$147.572.6% of flowCommon StockSEC:0001209191-23-016054:0
4,211 shares@ US$108.5215.5% of flowCommon StockSEC:0001209191-22-058284:0
1,216 shares@ US$79.203.3% of flowCommon StockSEC:0001209191-22-017343:0
572 shares@ US$75.051.4% of flowCommon StockSEC:0001209191-22-014409:0
3,780 shares@ US$79.3310.0% of flowCommon StockSEC:0001209191-21-066948:0
Canonical exit: 22 Feb 2022 (T+90)
40,000 shares0Common StockSEC:0001209191-21-065314:0
23 of 23 declarations
About Rodino-Klapac Louise
Rodino-Klapac Louise is Directeur Scientifique and President, R&D and Tech Ops at Sarepta Therapeutics, Inc. She has 23 filings in total. Across the 23 sampled filings, buys total EUR 266669 and sells total EUR 0, with filings ranging from 2021-11-17 to 2026-03-13. The most common transaction nature is Tax withholding.
